| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EYPT | Stock Option (right to buy) | Gift | $0 | -21.3K | -100% | $0.00* | 0 | May 11, 2023 | Common Stock | 21.3K | $36.30 | Direct | F1, F2 |
| transaction | EYPT | Stock Option (right to buy) | Gift | $0 | +21.3K | +33.33% | $0.00 | 85K | May 11, 2023 | Common Stock | 21.3K | $36.30 | By Family Trust | F1, F2, F3 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | -65.9K | -100% | $0.00* | 0 | May 11, 2023 | Common Stock | 65.9K | $26.50 | Direct | F4, F5 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | +65.9K | +242.77% | $0.00 | 93K | May 11, 2023 | Common Stock | 65.9K | $26.50 | By Family Trust | F3, F4, F5 |
| transaction | EYPT | Stock Option (right to buy) | Gift | $0 | -36K | -100% | $0.00* | 0 | May 11, 2023 | Common Stock | 36K | $20.40 | Direct | F6, F7 |
| transaction | EYPT | Stock Option (right to buy) | Gift | $0 | +36K | +200% | $0.00 | 54K | May 11, 2023 | Common Stock | 36K | $20.40 | By Family Trust | F3, F6, F7 |
| transaction | EYPT | Stock Option (right to buy) | Gift | $0 | -8K | -100% | $0.00* | 0 | May 11, 2023 | Common Stock | 8K | $17.70 | Direct | F8, F9 |
| transaction | EYPT | Stock Option (right to buy) | Gift | $0 | +8K | +50% | $0.00 | 24K | May 11, 2023 | Common Stock | 8K | $17.70 | By Family Trust | F3, F8, F9 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | -120K | -56.25% | $0.00 | 93.5K | May 11, 2023 | Common Stock | 120K | $13.13 | Direct | F10, F11 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | +120K | $0.00 | 120K | May 11, 2023 | Common Stock | 120K | $13.13 | By Family Trust | F3, F10, F11 | |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | -59.2K | -79.17% | $0.00 | 15.6K | May 11, 2023 | Common Stock | 59.2K | $12.90 | Direct | F12, F13 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | +59.2K | $0.00 | 59.2K | May 11, 2023 | Common Stock | 59.2K | $12.90 | By Family Trust | F3, F12, F13 | |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | -75K | -31.25% | $0.00 | 165K | May 11, 2023 | Common Stock | 75K | $10.13 | Direct | F14, F15 |
| transaction | EYPT | Stock Option (Right to Buy) | Gift | $0 | +75K | $0.00 | 75K | May 11, 2023 | Common Stock | 75K | $10.13 | By Family Trust | F3, F14, F15 |
| Id | Content |
|---|---|
| F1 | On May 11, 2023, the reporting person transferred the vested portion of an option to purchase common stock, par value $0.001 per share ("Common Stock"), of EyePoint Pharmaceuticals, Inc. (the "Company"), to an irrevocable family trust of which the reporting person's spouse is trustee and of which the reporting person's immediately family members are the sole beneficiaries (the "Family Trust"). The option was originally granted to the reporting person on December 12, 2016 and was exercisable for 85,000 shares of Common Stock of the Company. At the time of the transfer the option was fully vested. |
| F10 | On May 11, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 9, 2021 and was exercisable for 213,700 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 120,206 shares of Common Stock of the Company. |
| F11 | The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of May 9, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2025. |
| F12 | On May 11, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 28, 2020 and was exercisable for 74,800 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 59,220 shares of Common Stock of the Company. |
| F13 | The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of April 28, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 28, 2024. |
| F14 | On May 11, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 9, 2022 and was exercisable for 240,000 shares of Common Stock of the Company. At the time of the transfer, the vested portion of the option consisted of 75,000 shares of Common Stock of the Company. |
| F15 | The option to purchase will vest and become exercisable over a four year period as follows: 25% at the one year anniversary of grant and then ratably over the remaining thirty-six months At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of May 9, 2023. The remaining portion of the option retained by the reporting person continues to vest on a monthly basis until February 9, 2026. |
| F2 | The option vested and became exercisable in four equal annual installments beginning on September 15, 2017. At the time of the transfer, the portion of the option that was transferred to the Family Trust had vested in full as of September 15, 2020. |
| F3 | These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. |
| F4 | On May 11, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on February 21, 2019 and was fully vested at the time of the transfer |
| F5 | The option vests and becomes exercisable ratably in 48 monthly installments beginning on March 21, 2019. At the time of the transfer, the portion of the option that was transferred to the Family Trust had vested in full as of March 21,2023. |
| F6 | On May 11, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on June 14, 2018 and was fully vested at the time of the transfer. |
| F7 | The option vests and becomes exercisable in three equal annual installments beginning on June 14, 2019. At the time of the transfer, the portion of the option that was transferred to the Family Trust vested in full as of June 14, 2021. |
| F8 | On May 11, 2023, the reporting person transferred the vested portion of an option to purchase Common Stock of the Company to the Family Trust. The option was originally granted to the reporting person on December 15, 2017 and was fully vested at the time of the transfer, |
| F9 | The option vested and became exercisable in three equal annual installments beginning on June 27, 2018. At the time of the transfer, the portion of the option that was transferred to the Family Trust had vested in full as of June 27, 2020. |